NKTR (Nektar Therapeutics) Short-Term Debt to Capital
Nektar Therapeutics (NKTR) is a recognized biopharmaceutical expert with an impeccable reputation and proprietary technology. The business focuses on developing methods to combat oncology and autoimmune pathologies by utilizing molecular modification to reduce harm and increase drug productivity. The reliability of component supply for research is guaranteed by strict control of supply chains. The price action (separate_debt_short_eq) is recorded at 0.02.
Analytical breakdowns for Nektar Therapeutics
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
Total Debt to Capital Nektar Therapeutics|NKTR - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Nektar Therapeutics Inc.|NKTR - Aggregate Debt Obligations|Debts to Book Capitalization Nektar Therapeutics Inc|NKTR - Long-Term Debt Volume|Company Short-Term Debt Nektar Therapeutics|Quick Liquidity nektar.com
- company profitability and valuation multiples indicators:
Fundamental valuation:Nektar
Nektar Therapeutics (NKTR) high-tech developments in immunology require significant capital expenditures, making the borrowing structure critical for business sustainability. This metric correlates liabilities with a maturity of up to one year against total equity, allowing this chart of short-term liability shares in capital to determine the balance between aggressive expansion and the risk of insolvency.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio PHAR|Short-Term Debt to Capital Upstream Pharma|Short-Term Debt to Equity Zenas Biopharma Inc (ZBIO)|immunome.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Current Liabilities to Capital|SEPN - Short-Term Debt to Equity|PVLA (Pieris Corp) - Short-Term Debt to Capital Ratio|SVRA: Short-Term Debt to Capital|Current Liabilities to Capital rigel.com (RIGL)|Short-Term Debt to Equity AnaptysBio|Short-Term Debt to Capital Astria Therapeutics Inc|Short-Term Debt to Equity Ratio ENGN (enGene Bio)|Short-Term Loans to Capital Ratio RAPT|Short-Term Debt to Capital JBIO (Aerovate Therapeutics)|Short-Term Debt to Capital aclaristx.com ACRS|KYTX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital TLSA (Tiziana Life Sciences Ltd.)|CABA (Cabaletta Bio, Inc) - Short-Term Debt to Equity Ratio|Ventyx Biosciences, Inc - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio THTX|AVTX (avalotx.com) - Short-Term Loans to Capital Ratio|Short-Term Debt to Capital ELDN|AGEN (Agenus, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital CLYM (Climb Bio, Inc.)|zurabio.com (ZURA) - Current Liabilities to Capital|ATYR - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital ADAG (Adagene)|IMA: Short-Term Debt to Capital|Shattuck Labs (STTK) - Short-Term Debt to Capital|Short-Term Debt to Equity Equillium Inc|Connect Pharma - Current Liabilities to Equity|Short-Term Debt to Capital IMUX|ATRA - Current Liabilities to Capital|InflaRx - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital X4 Pharmaceuticals Inc. XFOR|ACET: Short-Term Debt to Equity Ratio|Celularity Inc. - Short-Term Loans to Capital Ratio|INMB: Short-Term Debt to Capital|BRNS - Short-Term Debt to Capital Coefficient|KZR (Kezar Life Sciences, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio SAB Biotherapeutics Inc. (SABS)|Short-Term Debt to Equity Akari Therapeutics plc (AKTX)|Short-Term Debt to Capital Coefficient enlivex.com|Short-Term Debt to Equity Q32 Bio QTTB|GOVX: Short-Term Debt to Capital Ratio|EDSA - Short-Term Debt to Equity|IBIO - Short-Term Debt to Capital|CARM (carismatx.com) - Short-Term Debt to Equity Ratio|XTLB: Short-Term Loans to Capital Ratio|Short-Term Debt to Equity Bolt Biotherapeutics Inc.|HCWB: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Aptevo Therapeutics (APVO)|AIM: Current Liabilities to Equity|Short-Term Debt to Capital ADTX (Aditxt, Inc.)|Ratio of Short-Term Indebtedness to Capital GRI|XORTX Therapeutics Inc. - Short-Term Debt to Capital|HIND - Short-Term Debt to Capital|Revelation Biosciences, Inc. (REVB) - Short-Term Debt to Equity|Indaptus Therapeutics Inc - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Scinai|Short-Term Debt to Equity Ratio CalciMedica Corp (CALI)|Short-Term Debt to Capital AFMD|Short-Term Debt to Capital allakos.com (ALLK)|HOOKIPA Pharma - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital IGMS|iTeos - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Ocean Biomedical Corp OCEA|TC Biopharm (TCBP) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio thirdharmonicbio.com